检索结果 - Ram Kalpatthi

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Long‐term use of the thrombopoietin‐mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP)

    Long‐term use of the thrombopoietin‐mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP) 由 James B. Bussel, Loan Hsieh, George R. Buchanan, Kimo C. Stine, Ram Kalpatthi, David J. Gnarra, Richard Ho, Kun Nie, Melissa Eisen

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Developmental Function in Toddlers With Sickle Cell Anemia

    Developmental Function in Toddlers With Sickle Cell Anemia 由 F. Daniel Armstrong, T. David Elkin, R. Clark Brown, Penny Glass, Sohail Rana, James F. Casella, Ram Kalpatthi, Steven G. Pavlakis, Zhibao Mi, Winfred C. Wang

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Immunologic Effects of Hydroxyurea in Sickle Cell Anemia

    Immunologic Effects of Hydroxyurea in Sickle Cell Anemia 由 Howard M. Lederman, Margaret A. Connolly, Ram Kalpatthi, Russell E. Ware, Winfred C. Wang, Lori Luchtman‐Jones, Myron A. Waclawiw, Jonathan C. Goldsmith, Andrea J. Swift, James F. Casella

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Impact of hydroxyurea on clinical events in the BABY HUG trial

    Impact of hydroxyurea on clinical events in the BABY HUG trial 由 Courtney D. Thornburg, Beatrice Files, Zhaoyu Luo, Scott T. Miller, Ram Kalpatthi, Rathi V. Iyer, Phillip Seaman, Jeffrey D. Lebensburger, Ofelia Álvarez, Bruce Thompson, Russell E. Ware, Winfred C. Wang

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11 years

    Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11 years 由 Jeremie H. Estepp, Ram Kalpatthi, Gerald M. Woods, Sara Trompeter, Robert I. Liem, Kacie Sims, Adlette Inati, Baba Inusa, Andrew Campbell, Connie M. Piccone, Miguel R. Abboud, Kim Smith‐Whitley, Sandra Dixon, Margaret Tonda, Carla Washington, Noelle M. Griffin, R. Clark Brown

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    The pediatric hydroxyurea phase III clinical trial (BABY HUG): Challenges of study design

    The pediatric hydroxyurea phase III clinical trial (BABY HUG): Challenges of study design 由 Bruce Thompson, Scott T. Miller, Zora R. Rogers, Renée C. Rees, Russell E. Ware, Myron A. Waclawiw, Rathi V. Iyer, James F. Casella, Lori Luchtman‐Jones, Sohail Rana, Courtney D. Thornburg, Ram Kalpatthi, Julio C. Barredo, R. Clark Brown, Sharada A. Sarnaik, Thomas H. Howard, Lori Luck, Winfred C. Wang

    出版 2009
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)

    Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG) 由 Winfred C. Wang, Russell E. Ware, Scott T. Miller, Rathi V. Iyer, James F. Casella, Caterina P. Minniti, Sohail Rana, Courtney D. Thornburg, Zora R. Rogers, Ram Kalpatthi, Julio C. Barredo, R. Clark Brown, Sharada A. Sarnaik, Thomas H. Howard, Lynn Wynn, Abdullah Kutlar, F. Daniel Armstrong, Beatrice Files, Jonathan C. Goldsmith, Myron A. Waclawiw, Xiangke Huang, Bruce Thompson

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: